ArriVent BioPharma (AVBP) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 18, 2026, with voting open until June 17, 2026 at 11:59 PM ET.

• Shareholders can access proxy materials online or request paper/email copies by June 4, 2026.

• Meeting will be held virtually, allowing remote participation and voting.

Voting matters and shareholder proposals

• Election of three directors: James Healy, John Hohneker, and Stuart Lutzker, all recommended by the board.

• Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.

• Provision for other business to be addressed as may properly come before the meeting.

Audit committee and external auditor matters

• Proposal to ratify PricewaterhouseCoopers LLP as the independent registered public accounting firm for the upcoming fiscal year.